Noncanonical Pathways of Proteasome Inhibition in HPV-Negative Head & Neck Cancer

Hye-Yeon Lee1, Ji-Yeong Kim1, Zhiyong Wang2

  • 1Department of Otorhinolaryngology-Head & Neck Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.

Molecular Carcinogenesis
|August 20, 2025
PubMed

Insights

Carfilzomib (CFZ) effectively inhibits head and neck cancer cell growth and induces apoptosis, particularly in HPV-negative HNSCC. This proteasome inhibitor shows promise in overcoming cisplatin resistance, suggesting a new therapeutic avenue.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Carfilzomib (CFZ) is a proteasome inhibitor used for multiple myeloma.
  • Its efficacy in head and neck squamous cell carcinoma (HNSCC), especially HPV-negative types, is not well-established.
  • Understanding CFZ's impact on HNSCC is crucial for developing new treatment strategies.

Purpose of the Study:

  • To evaluate the anticancer potential of carfilzomib (CFZ) in HPV-positive and HPV-negative head and neck cancer cells (HNSCC).
  • To investigate the mechanisms underlying CFZ's effects on HNSCC proliferation and apoptosis.
  • To assess CFZ's efficacy in overcoming cisplatin resistance in HPV-negative HNSCC.

Main Methods:

  • In vitro assessment of CFZ's IC50 in various HNSCC cell lines.
  • Analysis of signaling pathways (PI3K/AKT/mTOR, p21) affected by CFZ treatment.
  • In vivo evaluation of CFZ's effect on tumor growth in mice bearing xenografted HPV-negative HNSCC cells.

Main Results:

  • CFZ demonstrated significantly higher potency (lower IC50) in HPV-negative CAL-27 HNSCC cells compared to other HNSCC lines.
  • CFZ inhibited Akt/mTOR signaling (p-Akt, p-S6) and activated p21, leading to growth inhibition and apoptosis in CAL-27 cells.
  • CFZ treatment reduced tumor growth in mice with xenografted HPV-negative CAL-27 tumors.

Conclusions:

  • Carfilzomib induces cytotoxic effects in HNSCC, primarily through cell growth inhibition and apoptosis via the PI3K/AKT/mTOR and p21 pathways.
  • CFZ demonstrates potential as a therapeutic agent for HPV-negative HNSCC, offering a strategy to overcome cisplatin resistance.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.2K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.6K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.3K